Lugano, Switzerland

Giovanna Libralon

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Allergan, Inc., Lundbeck Pharmaceuticals, Italy. Active years: 2013-2017.


% Patents Active = 75.0


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Galliera Veneta, IT (2013)
  • Lugano, CH (2014 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Giovanna Libralon: Innovator in Pharmaceutical Chemistry

Introduction

Giovanna Libralon is a notable inventor based in Lugano, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for pain treatment. With a total of 4 patents to her name, her work continues to impact the medical community.

Latest Patents

Among her latest patents is the invention of (−)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt. This invention includes a pharmaceutical composition comprising the salt, a process for its production, and its application in pain management. The focus of this patent is to provide an effective treatment option for patients suffering from pain.

Career Highlights

Giovanna has worked with prominent companies in the pharmaceutical industry, including Allergan, Inc. and Lundbeck Pharmaceuticals Italy S.p.a. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Throughout her career, Giovanna has collaborated with talented professionals, including Jacopo Zanon and Carla De Faveri. These partnerships have fostered a creative environment that has led to innovative solutions in pharmaceutical development.

Conclusion

Giovanna Libralon's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving patient care. Her patents and collaborations highlight her role as a key figure in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…